data
query
queries
{
"author": {
"name": "Fiona Rutherford",
"webUrl": "/author/profile/fiona-rutherford/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 5,
"social": [],
"articles": [
{
"uri": "/2023/08/31/drugstore-disruptors-walmart-cvs-want-patients-to-skip-trips-to-the-doctor/",
"title": "Drugstore disruptors? Walmart, CVS want patients to skip trips to the doctor",
"byline": "Fiona Rutherford and Brendan Case",
"kicker": "News",
"prettyDate": "August 31, 2023",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/08/Walmart-Walgreens-CVS-Article-202308291351.jpg",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/fiona-rutherford/",
"name": "Fiona Rutherford"
},
{
"webUrl": "/author/profile/brendan-case/",
"name": "Brendan Case"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The big chains are angling for a larger slice of health care spending as new state laws allow pharmacists to treat minor ailments.",
"body": null
},
{
"uri": "/2023/05/19/sareptas-gene-therapy-gets-accelerated-approval-are-fda-fast-tracked-drugs-safe/",
"title": "Sarepta's gene therapy gets FDA accelerated approval: Are fast-tracked drugs safe?",
"byline": "Robert Langreth, Fiona Rutherford, Immanual John Milton and Madeline Campbell",
"kicker": "Market Insights",
"prettyDate": "May 19, 2023",
"timeToRead": "9 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/09/Pharmaceutical-Lab-Article-202009151515.jpg",
"width": "0",
"height": "0"
},
"authors": [
{
"webUrl": "/author/profile/robert-langreth-fiona-rutherford-immanual-john-milton/",
"name": "Robert Langreth, Fiona Rutherford, Immanual John Milton"
},
{
"webUrl": "/author/profile/madeline-campbell/",
"name": "Madeline Campbell"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "The recommendation is a huge win for the pharmaceutical company, likely paving the way for the company's first-of-its-kind gene therapy for treat Duchenne muscular dystrophy, a deadly disease.",
"body": null
},
{
"uri": "/2023/04/19/fda-authorizes-covid-booster-for-some-high-risk-and-older-americans/",
"title": "FDA authorizes COVID booster for some high-risk and older Americans",
"byline": "Madison Muller and Fiona Rutherford",
"kicker": "News",
"prettyDate": "April 19, 2023",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2021/04/fav-covid-vaccine.jpg",
"width": "616",
"height": "411"
},
"authors": [
{
"webUrl": "/author/profile/madison-muller/",
"name": "Madison Muller"
},
{
"webUrl": "/author/profile/fiona-rutherford/",
"name": "Fiona Rutherford"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The agency also simplified the COVID vaccination process, saying that anyone getting a Pfizer or Moderna dose — whether it's a booster or their first-ever vaccination — will get the newest formula, not the original shots.",
"body": null
},
{
"uri": "/2023/02/08/cvs-pays-10-6b-for-oak-street-health-primary-care-centers/",
"title": "CVS pays $10.6B for Oak Street Health primary care centers",
"byline": "Michelle F. Davis, Fiona Rutherford and John Tozzi",
"kicker": "News",
"prettyDate": "February 08, 2023",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/04/cvs-ap.jpg",
"width": "617",
"height": "411"
},
"authors": [
{
"webUrl": "/author/profile/michelle-f-davis-fiona-rutherford/",
"name": "Michelle F. Davis, Fiona Rutherford"
},
{
"webUrl": "/author/profile/john-tozzi/",
"name": "John Tozzi"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "In its third largest deal in the last decade, the pharmacy chain digs deeper into health care services, after buying Oak Street, which runs clinics that specialize in treating Medicare Advantage patients.",
"body": null
},
{
"uri": "/2022/08/31/fda-clears-way-for-boosters-targeted-at-latest-covid-omicron-variants/",
"title": "FDA clears way for boosters targeted at latest COVID Omicron variants",
"byline": "Fiona Rutherford",
"kicker": "News",
"prettyDate": "August 31, 2022",
"timeToRead": "2 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2021/12/381968548.jpg",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/fiona-rutherford/",
"name": "Fiona Rutherford"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The Biden administration has made plans to begin offering the new boosters as soon as the Labor Day weekend.",
"body": null
}
]
}
}